冷泉港亚洲2013会议：疫苗设计
Vaccine Design
疫苗设计
2013年6月3-7日 | 苏州独墅湖会议酒店
|
科学组委会成员: Michael Good, Griffith University, AUSTRALIA Yiming Shao, Chinese Center for Disease Control and Prevention, CHINA Linqi Zhang, Tsinghua University, CHINA |
主题演讲嘉宾:
Dennis Burton, The Scripps Research Institute, USA
HIV vaccine targets identified by broadly neutralizing antibodies
David Ho, Aaron Diamond AIDS Res Center, USA
Potent Neutralizing Monoclonal Antibodies as Passive Vaccines against HIV
Dennis Burton, The Scripps Research Institute, USA
HIV vaccine targets identified by broadly neutralizing antibodies
David Ho, Aaron Diamond AIDS Res Center, USA
Potent Neutralizing Monoclonal Antibodies as Passive Vaccines against HIV
特邀演讲嘉宾:
Gabrielle Belz, Walter and Eliza Hall Institute of Medical Research, Australia
Sentinal protection of mucosal tissues - insights to development, lineage relationships and protection by innate lymphoid cells
Michael Good, Griffith University, AUSTRALIA
Strain and species-transcending immunity induced by exposure to low doses of blood stage malaria parasites - a new paradigm for vaccine development
Ken Ishii, National Institute of Biomedical Innovation(NIBIO), Immunology Frontier Research Center (IFREC), Osaka University, Japan
Biomarkers and molecular mechanisms of vaccine adjuvant
Rajiv Khanna, Queensland Institute of Medical Research, Australia
Challenges in designing prophylactic vaccines against human herpesviruses
David Klatzmann, UMR 7211 UPMC/CNRS, Pierre & Marie Curie University, France
Towards preventive and therapeutic HCV vaccines: induction of broadly neutralizing antibodies using a novel VLP-based vaccine platform
Mi-Na Kweon, International Vaccine Institute, Korea
Acute epithelial death plays a role in intrinsic defense against enteric bacteria
Thomas Lehner, Kings College London, UK
The protective mechanism of innate ApoBECgG deaminase and adaptive activation induced deaminase (AID) in HLA-HIV immunised macaqires
Larry (Huaxin) Liao, Duke University Medical Center, USA
The Path Forward For HIV Vaccine Development: Regulation of Protective Antibodies
Shan Lu, University of Massachusetts Medical Center, USA
DNA vaccination at the cross road of acquired and innate immunities
M. Juliana McElrath, Fred Hutchinson Cancer Research Center, USA
HIV Vaccine-Induced Immunity
James Mullins, University of Washington, USA
Alteration of the immundominance hierarchy of HIV-1 Gag induced by a DNA vaccine expressing conserved elements of p24gag in macaques
David Pascual, Montana State University, USA
Mucosal Vaccination Protects Against Pulmonary and Systemic Brucellosis
Ruth Ruprecht, Dana-Farber Cancer Institute, USA
Humoral Correlates of Protection against Mucosal Simian-human Immunodeficiency Virus Transmission
Yiming Shao, Chinese Center for Disease Control and Prevention, China
The past achievement, current challenges and future opportunities for vaccine research in China
Zhong Su, Guangzhou Institutes of Biomedicine and Health, China
Development of a transgenic whole pathogen blood-stage malaria vaccine
Richard Wyatt, The Scripps Research Institute, USA
HIV-1 envelope glycoprotein immunogen/vaccine design and analysis
Cassian Yee, University of Washington, USA
T Cell Therapy and Cancer Vaccines: Two sides. Same Coin
Linqi Zhang, Tsinghua University, China
Antibody profiling, epitope mapping and vaccine design based on yeast surface display system
Tongqing Zhou, Vaccine Research Center, NIAID/NIH, USA
From antibody to antibodyome: Seeking the coordinates for an effective HIV-1 vaccine
Jiang Zhu, NIH/NIAID, USA
Combining Deep Sequencing and Protein Design - A Systematic Approach to Vaccine Development
Gabrielle Belz, Walter and Eliza Hall Institute of Medical Research, Australia
Sentinal protection of mucosal tissues - insights to development, lineage relationships and protection by innate lymphoid cells
Michael Good, Griffith University, AUSTRALIA
Strain and species-transcending immunity induced by exposure to low doses of blood stage malaria parasites - a new paradigm for vaccine development
Ken Ishii, National Institute of Biomedical Innovation(NIBIO), Immunology Frontier Research Center (IFREC), Osaka University, Japan
Biomarkers and molecular mechanisms of vaccine adjuvant
Rajiv Khanna, Queensland Institute of Medical Research, Australia
Challenges in designing prophylactic vaccines against human herpesviruses
David Klatzmann, UMR 7211 UPMC/CNRS, Pierre & Marie Curie University, France
Towards preventive and therapeutic HCV vaccines: induction of broadly neutralizing antibodies using a novel VLP-based vaccine platform
Mi-Na Kweon, International Vaccine Institute, Korea
Acute epithelial death plays a role in intrinsic defense against enteric bacteria
Thomas Lehner, Kings College London, UK
The protective mechanism of innate ApoBECgG deaminase and adaptive activation induced deaminase (AID) in HLA-HIV immunised macaqires
Larry (Huaxin) Liao, Duke University Medical Center, USA
The Path Forward For HIV Vaccine Development: Regulation of Protective Antibodies
Shan Lu, University of Massachusetts Medical Center, USA
DNA vaccination at the cross road of acquired and innate immunities
M. Juliana McElrath, Fred Hutchinson Cancer Research Center, USA
HIV Vaccine-Induced Immunity
James Mullins, University of Washington, USA
Alteration of the immundominance hierarchy of HIV-1 Gag induced by a DNA vaccine expressing conserved elements of p24gag in macaques
David Pascual, Montana State University, USA
Mucosal Vaccination Protects Against Pulmonary and Systemic Brucellosis
Ruth Ruprecht, Dana-Farber Cancer Institute, USA
Humoral Correlates of Protection against Mucosal Simian-human Immunodeficiency Virus Transmission
Yiming Shao, Chinese Center for Disease Control and Prevention, China
The past achievement, current challenges and future opportunities for vaccine research in China
Zhong Su, Guangzhou Institutes of Biomedicine and Health, China
Development of a transgenic whole pathogen blood-stage malaria vaccine
Richard Wyatt, The Scripps Research Institute, USA
HIV-1 envelope glycoprotein immunogen/vaccine design and analysis
Cassian Yee, University of Washington, USA
T Cell Therapy and Cancer Vaccines: Two sides. Same Coin
Linqi Zhang, Tsinghua University, China
Antibody profiling, epitope mapping and vaccine design based on yeast surface display system
Tongqing Zhou, Vaccine Research Center, NIAID/NIH, USA
From antibody to antibodyome: Seeking the coordinates for an effective HIV-1 vaccine
Jiang Zhu, NIH/NIAID, USA
Combining Deep Sequencing and Protein Design - A Systematic Approach to Vaccine Development
会议主题：
1. Immunology of vaccine
Focus on basic understanding how an effective vaccine may/should work including innate immunity, adjuvants, systems biological approaches to studying immune responses in humans etc.
2. Translating immunity to vaccine against leading diseases: HIV, malaria, TB, cancer and others
Focus on vaccine design, delivery, evaluation through various novel approach including systems biology.
3. Antibody and vaccine development
This session will focus more on some of the newer ideas and approaches to systemically characterize the initiation, evolution and maturation of immune responses in infected and vaccinated individuals. Novel ideas in vaccine design based on structure-function relationship between antibodyantigen should also been highlighted.
1. Immunology of vaccine
Focus on basic understanding how an effective vaccine may/should work including innate immunity, adjuvants, systems biological approaches to studying immune responses in humans etc.
2. Translating immunity to vaccine against leading diseases: HIV, malaria, TB, cancer and others
Focus on vaccine design, delivery, evaluation through various novel approach including systems biology.
3. Antibody and vaccine development
This session will focus more on some of the newer ideas and approaches to systemically characterize the initiation, evolution and maturation of immune responses in infected and vaccinated individuals. Novel ideas in vaccine design based on structure-function relationship between antibodyantigen should also been highlighted.
|
|
联系方式： Cold Spring Harbor Asia No.299 Qiyue Road, SIP/ Suzhou, Jiangsu Province, China Tel: +86-512-62729029 Fax: +86-512-62729028 Email: mikeji@cshl.edu Website: www.csh-asia.org |
相关链接： 2013年冷泉港亚洲（CSH Asia）会议抢先预览！
- 美森细胞与您相约第十五届棒棰岛肿瘤前沿论坛
- IGC第12届细胞及基因治疗研发与产业化论坛议程首发
- 恒通瑞安参与2026年肝脏疾病先进疗法学术会议
- 维拓启创即将亮相2026国际近红外光谱学会全球大会
- 艾普拜邀您共赴合成生物学驱动的功能材料和器件会议
- 朗喜工业邀您相聚2026慕尼黑分析生化中国展
- 2026第二届中国生物制药大会暨展览会通知
- 2026全国植物生物学大会通知
- CPHI思享会-第六届医药创新与临床转化年会通知
- 链接日本，共话新机遇，博鹭腾亮相BioJapan 2026
- 22家德国展商集结analytica China 2026德国展团
- 复纳科技邀您参加2026全国电镜年会·午餐会
- GMH 2026全球医疗健康（上海）展览会限时免费报名
- 2026合成生物学与酶工程赋能发酵技术研讨会通知
- 2026人因工程与智能系统交互国际会议第二轮通知
- 优宁维BD流式常用热门抗体与经典荧光素特惠来袭
- 专属福利：赛默飞分子生物学工具及抗体年度钜惠
- 优宁维蛋白翻译后修饰专题线上讲座及同步促销开启
- 优宁维开学季限时福利,CST全线抗体买3送1,多买多送
- 优宁维限时促销，Starter抗体、Absin小分子最低5折
- 佰傲谷&东富龙抗体工艺主题沙龙参会指南
- 优宁维CST抗体夏日促销开启，经典一抗买大送小
- 斯达特西湖寻兔小卡活动启航，购买正装抗体附赠小卡
- 爱必信Absin流式抗体限时促销，百元起现货直发
- 优宁维夏日双重限时促销,MiniAb抗体5折、WB试剂38折
- 菲恩生物邀您相约台北参加2026亚洲生技大展
- 研生生物锌指转录因子Slug+SNAIL抗体8折特惠开启
- 优宁维联合CST抗体限时特惠，解锁指定WB试剂38折
- 研生生物NT5DC2蛋白抗体阶梯折扣优惠，赠配套试剂
- 睿捷生物成为功能性抗体Bio X Cell战略授权经销商
